BIAL - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
85583401
Registration Number
4490162
Word Mark
BIAL
Status
710 - Cancelled - Section 8
Status Date
2020-10-09
Filing Date
2012-03-29
Registration Number
4490162
Registration Date
2014-03-04
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2013-03-19
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
GAYNOR, BARBARA ANNE
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized letters "BIAL".
Goods and Services
Pharmaceutical preparations for the treatment of cardiovascular diseases, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations; pharmaceutical preparations, namely, decongestants and anti-histamines; pharmaceutical preparations for the treatment of pains, cough, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; anaesthetics; analgesics; frostbite salve for pharmaceutical purposes; hemorrhoid treatment preparations; pharmaceutical preparations for the treatment of headaches; medicines for alleviating constipation; contraceptive preparations; radiological contrast substances for medical purposes; diagnostic preparations for medical purposes; pharmaceuticals for the treatment of pain, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations for the prevention and treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and treatment of tumours of any description; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, bipolar disorder, neuropathic pain, migraine, generalized anxiety disorder, social phobia, diabetic neuropathies, panic disorder, postoperative pain, back pain, fibromyalgia, and postherpetic neuralgia, post-traumatic stress disorder, Parkinson's disease, Alzheimers; pharmaceutical preparations for the treatment of psychiatric diseases, namely, schizophrenia, anxiety disorders, mood disorders, cognitive disorders, depression, mania; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system; pharmaceutical preparations for treatment of gout, namely, broncho-dilators and anti-asthmatic preparations; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anaesthesia, oncology; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations and substances, namely, antibiotics, antivirals, antidiabetic preparations, nondepolarizing skeletal neuromuscular blocking agents, hemostatic agents, expectorants, anti-leukemia agents, anti-arrhythmics, dermatologicals and vasopressors; pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity, and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI); cerebral vasodilators; pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles, and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, and spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations, namely, muscle relaxants and anti-emetics, xanthine oxidase inhibitors; pharmaceutical preparations, namely, scabicides, anti-malarials
Goods and Services
Pharmaceutical, medical and biological research and development in the field of human therapeutics; conducting of pre-clinical and clinical test research in the pharmaceutical and medical fields; scientific research and development in the field of human medicine
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-10-09
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-10-09
Primary Code
042
Correspondences
Name
JAMES L BIKOFF
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
0000-00-00 | Portugal | False |
Trademark Events
Event Date | Event Description |
2012-04-02 | NEW APPLICATION ENTERED IN TRAM |
2012-04-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2012-07-10 | ASSIGNED TO EXAMINER |
2012-07-11 | NON-FINAL ACTION WRITTEN |
2012-07-11 | NON-FINAL ACTION E-MAILED |
2012-07-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2013-01-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2013-01-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2013-01-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2013-01-31 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2013-02-11 | ASSIGNED TO LIE |
2013-02-11 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2013-02-27 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2013-03-19 | PUBLISHED FOR OPPOSITION |
2013-03-19 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2013-04-16 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2013-07-16 | OPPOSITION INSTITUTED NO. 999999 |
2014-01-28 | OPPOSITION DISMISSED NO. 999999 |
2014-01-28 | OPPOSITION TERMINATED NO. 999999 |
2014-01-28 | TTAB RELEASE CASE TO TRADEMARKS |
2014-01-28 | PAPER RECEIVED |
2014-03-04 | REGISTERED-PRINCIPAL REGISTER |
2015-01-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2019-03-04 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2020-10-09 | CANCELLED SEC. 8 (6-YR) |